Google
RVLPQ 株価分析 — RVL Pharmaceuticals PLC (Healthcare >> Biotechnology)
RVLPQ に関するよくある質問
RVLPQのROE（自己資本利益率）は？
RVL Pharmaceuticals PLCのROEは-418.14%です。
RVLPQの配当利回りは？
RVL Pharmaceuticals PLCの配当利回りは0.00%です。
RVLPQの品質スコア（Quality Score）は？
当社のAIはRVLPQの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
RVLPQはどのセクターに属しますか？
RVL Pharmaceuticals PLCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
RVLPQ AI Analysis Summary
Our AI summary for RVLPQ: RVL Pharmaceuticals PLC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -418.14%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD N/A
Price
0
(0%)
Day Change
|
|
|---|
Not enough data to analyze.
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | N/A |
| PBV / Sector |
N/A / 44,022.72
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / 19.17
|
| PEG or PE/Growth / Sector |
N/A / 1.24
|
| Average 1M Daily Value |
0.000000000000
|
| Average 1W Daily Value |
0.000000000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-05 08:00:48 |
| Symbol | RVLPQ |
| Name | RVL PHARMACEUTICALS PLC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 111.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | N/A / 9,586.08 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Phone: 908 809 1300
Website: https://www.rvlpharma.com
Employees: 125
Sector: Healthcare >> Biotechnology
Description: RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
